These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of prostacyclin as a natural deterrent to hematogenous tumor metastasis. Honn KV; Menter DG; Onoda JM; Taylor JD; Sloane BF Symp Fundam Cancer Res; 1983; 36():361-88. PubMed ID: 6382514 [No Abstract] [Full Text] [Related]
3. Prostacyclin and thromboxanes. Implications for their role in tumor cell metastasis. Honn KV; Busse WD; Sloane BF Biochem Pharmacol; 1983 Jan; 32(1):1-11. PubMed ID: 6338880 [No Abstract] [Full Text] [Related]
4. Tumor cell-platelet aggregation: induced by cathepsin B-like proteinase and inhibited by prostacyclin. Honn KV; Cavanaugh P; Evens C; Taylor JD; Sloane BF Science; 1982 Aug; 217(4559):540-2. PubMed ID: 7046053 [TBL] [Abstract][Full Text] [Related]
5. [Role of prostaglandins, thromboxanes and prostacyclin in regulating the thrombocyte aggregation process and liberation reaction normally and in pathology]. Baluda VP; Sushkevich GN; Lukoianova TI Patol Fiziol Eksp Ter; 1980; (4):80-5. PubMed ID: 6251418 [No Abstract] [Full Text] [Related]
6. A review of prostaglandins and the treatment of tumor metastasis. Honn KV; Menter D; Cavanaugh PG; Neagos G; Moilanen D; Taylor JD; Sloane BF Acta Clin Belg; 1983; 38(1):53-67. PubMed ID: 6405568 [No Abstract] [Full Text] [Related]
7. [Function of prostaglandins in platelet aggregation]. Sun QW Sheng Li Ke Xue Jin Zhan; 1980 Feb; 11(2):137-42. PubMed ID: 7001620 [No Abstract] [Full Text] [Related]
8. The role of prostacyclin and thromboxane A2 in the regulation of platelet behaviour. Moncada S Mater Med Pol; 1980; 12(3):207-12. PubMed ID: 7019591 [No Abstract] [Full Text] [Related]
9. Platelet aggregation inhibitors and cancer metastasis. Gastpar H Ann Chir Gynaecol; 1982; 71(3):142-50. PubMed ID: 6287902 [No Abstract] [Full Text] [Related]
11. Inhibition by prostacyclin of the tumor cell-induced platelet release reaction and platelet aggregation. Menter DG; Onoda JM; Moilanen D; Sloane BF; Taylor JD; Honn KV J Natl Cancer Inst; 1987 May; 78(5):961-9. PubMed ID: 3553692 [TBL] [Abstract][Full Text] [Related]
12. Thromboxane and prostacyclin: implications for function and disease of the vasculature. McGiff JC Adv Intern Med; 1980; 25():199-216. PubMed ID: 6987841 [No Abstract] [Full Text] [Related]
13. Effects of prostacyclin on tumor cell-induced platelet aggregation. Menter DG; Onoda JM; Taylor JD; Honn KV Cancer Res; 1984 Feb; 44(2):450-6. PubMed ID: 6362850 [TBL] [Abstract][Full Text] [Related]
14. Platelet cancer cell interaction in metastasis formation. Platelet aggregation inhibitors: a possible approach to metastasis prevention. Gastpar H; Ambrus JL; Ambrus CM Prog Clin Biol Res; 1982; 89():63-82. PubMed ID: 7111310 [TBL] [Abstract][Full Text] [Related]
16. Significance of prostaglandins and thromboxane A2 for the mode of action of cardiovascular drugs. Förster W Adv Prostaglandin Thromboxane Res; 1980; 7():609-18. PubMed ID: 6989188 [No Abstract] [Full Text] [Related]
17. Role of prostaglandins, prostacyclin, and thromboxanes in the physiologic control of the uterus and in parturition. Novy MJ; Liggins GC Semin Perinatol; 1980 Jan; 4(1):45-66. PubMed ID: 6770468 [No Abstract] [Full Text] [Related]
18. Studies on the biological balance between thromboxanes and prostacyclins in relation to the platelet-vessel wall interaction. Jørgensen KA Dan Med Bull; 1982 May; 29(4):169-97. PubMed ID: 6286257 [No Abstract] [Full Text] [Related]
19. [The action of thromboxanes and prostacyclins on platelet function]. Nechifor M Rev Med Chir Soc Med Nat Iasi; 1980; 84(1):15-9. PubMed ID: 6994194 [No Abstract] [Full Text] [Related]